Cargando…

The Ubiquitin Proteasome System in Hematological Malignancies: New Insight into Its Functional Role and Therapeutic Options

The ubiquitin proteasome system (UPS) is the main cellular degradation machinery designed for controlling turnover of critical proteins involved in cancer pathogenesis, including hematological malignancies. UPS plays a functional role in regulating turnover of key proteins involved in cell cycle arr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Di Costanzo, Antonella, Del Gaudio, Nunzio, Conte, Lidio, Altucci, Lucia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409207/ https://www.ncbi.nlm.nih.gov/pubmed/32674429 http://dx.doi.org/10.3390/cancers12071898

Ejemplares similares

The HDAC inhibitor SAHA regulates CBX2 stability via a SUMO-triggered ubiquitin-mediated pathway in leukemia
por: Di Costanzo, Antonella, et al.
Publicado: (2018)

BRD9 binds cell type-specific chromatin regions regulating leukemic cell survival via STAT5 inhibition
por: Del Gaudio, Nunzio, et al.
Publicado: (2019)

KDM4 Involvement in Breast Cancer and Possible Therapeutic Approaches
por: Varghese, Benluvankar, et al.
Publicado: (2021)

CBX2 shapes chromatin accessibility promoting AML via p38 MAPK signaling pathway
por: Del Gaudio, Nunzio, et al.
Publicado: (2022)

Dysregulation of the Ubiquitin Proteasome System in Human Malignancies: A Window for Therapeutic Intervention
por: Fhu, Chee Wai, et al.
Publicado: (2021)

HDAC6 Inhibition Extinguishes Autophagy in Cancer: Recent Insights
por: Passaro, Eugenia, et al.
Publicado: (2021)

Ubiquitin Engineering for Interrogating the Ubiquitin–Proteasome System and Novel Therapeutic Strategies
por: Tang, Jason Q., et al.
Publicado: (2023)

HPV Oncoproteins and the Ubiquitin Proteasome System: A Signature of Malignancy?
por: Đukić, Anamaria, et al.
Publicado: (2020)

Histone deacetylase inhibitors: clinical implications for hematological malignancies
por: Tambaro, Francesco Paolo, et al.
Publicado: (2010)

Insights into the ubiquitin-proteasome system of human embryonic stem cells
por: Saez, Isabel, et al.
Publicado: (2018)

CAR-engineered NK cells; a promising therapeutic option for treatment of hematological malignancies
por: Marofi, Faroogh, et al.
Publicado: (2021)

Centrosome Defects in Hematological Malignancies: Molecular Mechanisms and Therapeutic Insights
por: Hu, Mingzheng, et al.
Publicado: (2022)

Phase 1 study of ixazomib, an investigational proteasome inhibitor, in advanced non-hematologic malignancies
por: Smith, David C., et al.
Publicado: (2015)

The ubiquitin-proteasome pathway in cancer.
por: Spataro, V., et al.
Publicado: (1998)

The ubiquitin proteasome system in neuropathology
por: Lehman, Norman L.
Publicado: (2009)

The recognition of ubiquitinated proteins by the proteasome
por: Grice, Guinevere L., et al.
Publicado: (2016)

Histone Deacetylase Inhibitors Impair Vasculogenic Mimicry from Glioblastoma Cells
por: Pastorino, Olga, et al.
Publicado: (2019)

Roles and potential therapeutic targets of the ubiquitin proteasome system in muscle wasting
por: Nury, David, et al.
Publicado: (2007)

Modulating the Ubiquitin–Proteasome System: A Therapeutic Strategy for Autoimmune Diseases
por: Yadav, Dhananjay, et al.
Publicado: (2022)

Targeting the Ubiquitin-Proteasome System for Cancer Therapeutics by Small-Molecule Inhibitors
por: LaPlante, Gabriel, et al.
Publicado: (2021)

Fertility-Preserving Treatment Options in Patients with Malignant Hematological Diseases
por: Küçük, Mert, et al.
Publicado: (2012)

Role of the ubiquitin/proteasome system on ACTH turnover in rat corticotropes
por: Sesta, Antonella, et al.
Publicado: (2018)

Unexpected and durable response with regorafenib in a metastatic colorectal cancer patient without KDR mutation: A case report
por: Rosati, Gerardo, et al.
Publicado: (2018)

The ubiquitin proteasome system in Caenorhabditis elegans and its regulation()
por: Papaevgeniou, Nikoletta, et al.
Publicado: (2014)

The Ubiquitin Conjugating Enzyme: An Important Ubiquitin Transfer Platform in Ubiquitin-Proteasome System
por: Liu, Weigang, et al.
Publicado: (2020)

Poxvirus Exploitation of the Ubiquitin-Proteasome System
por: Barry, Michele, et al.
Publicado: (2010)

The Ubiquitin-Proteasome Pathway in Huntington's Disease
por: Mitra, Siddhartha, et al.
Publicado: (2008)

Enzymatic Blockade of the Ubiquitin-Proteasome Pathway
por: Ernst, Robert, et al.
Publicado: (2011)

The ubiquitin-proteasome system in Alzheimer's disease
por: Oddo, Salvatore
Publicado: (2008)

Autoregulation of the 26S proteasome by in situ ubiquitination
por: Jacobson, Andrew D., et al.
Publicado: (2014)

Ubiquitin Proteasome System in Stress and Disease
por: Karpov, Dmitry, et al.
Publicado: (2012)

Intracellular Dynamics of the Ubiquitin-Proteasome-System
por: Chowdhury, Maisha, et al.
Publicado: (2015)

Ubiquitin-Proteasome System in Neurodegenerative Disorders
por: Rao, Geeta, et al.
Publicado: (2015)

The Ubiquitin–Proteasome System in Immune Cells
por: Çetin, Gonca, et al.
Publicado: (2021)

Ubiquitin-proteasome system in diabetic retinopathy
por: Svikle, Zane, et al.
Publicado: (2022)

Copper homeostasis and the ubiquitin proteasome system
por: Zhang, Bichao, et al.
Publicado: (2023)

The Ubiquitin–Proteasome System in Tumor Metabolism
por: Wang, Jie, et al.
Publicado: (2023)

S-Nitrosation and Ubiquitin-Proteasome System Interplay in Neuromuscular Disorders
por: Rizza, Salvatore, et al.
Publicado: (2014)

The ubiquitin-proteasome system is required for African swine fever replication
por: Barrado-Gil, Lucía, et al.
Publicado: (2017)

Therapeutic Benefits of Selenium in Hematological Malignancies
por: Ehudin, Melanie A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_85j4l3pg7besbenq8ef8q2ev46